C the Signs

Series-A
cthesigns.com Biotech & Healthcare London, United Kingdom
Total Funding $8M
Latest Round $8M Series-A
Last Announced Jan 30, 2025
Investors 8 Backers
Decision Makers 2 Verified

About C the Signs

C the Signs is an MHRA Class I medical device helping GPs detect and refer patients at risk of cancer earlier, when survival is highest.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters London, United Kingdom
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website cthesigns.com
Domain Registered Date Jun 12, 2013

Social & Network Presence

X / Twitter Profile @CtheSignsSystem (1.1K followers) Created on Oct 2012
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $8,000,000 · Venture Round

    fundraisingfox.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    Website domain registered

    cthesigns.com

  4. Milestone

    X account created (@CtheSignsSystem)

    1.1K followers

Investors & Backers

8
Acequia Capital (AceCap)
Ataraxia
CancerX Startup Accelerator
Joyance Partners
Khosla Ventures
MMC Ventures
Pitch@Palace
SBRI Healthcare

Funding History

2 Rounds
Venture Round · Jan 30, 2025
Series-A · Feb 4, 2022

Founders & Leadership

3

Bhavagaya Bakshi

Co-founder & CEO

Work email & phone locked Unlock →

Miles Payling

Co-founder and Chief Scientific Officer

Work email & phone locked Unlock →

Todd Rothenhaus

Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts